Therapeutic clinical trial enrollment does not match glioma incidence across demographics.
Traditional statistical methods have identified independent predictors of trial enrollment; however, our understanding of the interactions between these factors remains limited.
To test the interactive effects of demographic, socioeconomic, and oncologic variables on trial enrollment, we designed boosted neural networks (BNNs) for all glioma patients (
